Healthcare - Biotechnology - NASDAQ - US
$ 2.21
-12.3 %
$ 271 M
Market Cap
-2.6
P/E
CASH FLOW STATEMENT
-169 M
OPERATING CASH FLOW
120 M
INVESTING CASH FLOW
94.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Mersana Therapeutics, Inc.
| Net Income | -172 M |
| Depreciation & Amortization | 1.52 M |
| Capital Expenditures | -2.17 M |
| Stock-Based Compensation | 21.1 M |
| Change in Working Capital | -18.8 M |
| Others | -43.8 M |
| Free Cash Flow | -171 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (171.7) | (204.2) | (170.1) | (88.0) | (28.2) | (64.3) | (38.7) | (13.7) | (16.4) |
| Depreciation & Amortization | 1.5 | 0.9 | 0.9 | 1.0 | 1.2 | 1.3 | 0.9 | 0.7 | 0.3 |
| Deferred Income Tax | 0 | 0 | 0 | 86 K | (0.2) | (0.4) | (0.1) | (0.1) | (0.3) |
| Stock Based Compensation | 21.1 | 21.5 | 18.4 | 7.2 | 4.9 | 3.9 | 1.4 | 0.7 | 0.3 |
| Other Operating Activities | (1.1) | (0.7) | 0.7 | 0.1 | 0.1 | 0.1 | (0.2) | 0.1 | 0.3 |
| Change in Working Capital | (18.8) | 133.1 | 10.1 | 5.1 | (45.5) | 4.2 | (6.0) | 44.0 | 6.1 |
| Cash From Operations | (168.9) | (49.4) | (140.0) | (74.7) | (67.7) | (55.2) | (42.7) | 31.6 | (9.6) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (2.2) | (2.2) | (0.6) | (0.5) | (0.6) | (1.4) | (1.1) | (1.1) | (0.6) |
| Other Items | 122.1 | (150.5) | 0 | 37.5 | (26.7) | 88.6 | (98.5) | 0 | (0.2) |
| Cash From Investing Activities | 119.9 | (152.7) | (0.6) | 37.0 | (27.3) | 87.2 | (99.6) | (1.1) | (0.8) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 |
| Total Debt Repaid | (0.3) | (0.3) | 18.3 | (0.1) | 4.9 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.4 | 2.4 | 2.2 | 3.5 | 0.7 | 1.1 | 0.5 | 58.3 | 10.0 |
| Cash From Financing Activities | 94.7 | 153.0 | 63.6 | 230.4 | 97.7 | 1.1 | 68.6 | 58.3 | 10.0 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | 45.7 | (49.1) | (77.0) | 192.7 | 2.7 | 33.0 | (73.7) | 88.8 | (0.5) |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (171.1) | (51.6) | (140.6) | (75.2) | (68.3) | (56.6) | (43.8) | 30.5 | (10.3) |